{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:34:36Z","timestamp":1793093676172,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Postgraduate Innovation Fund of China State Institute of Pharmaceutical Industry Co Ltd."},{"name":"the Natural Science Foundation of Shanghai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41429-025-00822-x","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:17:49Z","timestamp":1745389069000},"page":"359-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel bifunctional antibacterial peptides mediated by a covalent conjugation strategy combat priority multidrug-resistant gram-negative pathogens through dual targets"],"prefix":"10.1038","volume":"78","author":[{"given":"Yanan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"822_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"822_CR2","unstructured":"WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"822_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","volume":"9","author":"M El-Sayed Ahmed","year":"2020","unstructured":"El-Sayed Ahmed M, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB. Colistin and Its Role in the Era of Antibiotic Resistance: An Extended Review (2000\u20132019). Emerg Microbes Infect. 2020;9:868\u201385.","journal-title":"Emerg Microbes Infect"},{"key":"822_CR4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/jac\/dkt531","volume":"69","author":"JY Lee","year":"2014","unstructured":"Lee JY, Na IY, Park YK, Ko KS. Genomic Variations between Colistin-Susceptible and -Resistant Pseudomonas Aeruginosa Clinical Isolates and Their Effects on Colistin Resistance. J Antimicrob Chemother. 2014;69:1248\u201356.","journal-title":"J Antimicrob Chemother"},{"key":"822_CR5","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1128\/AAC.05391-11","volume":"55","author":"AK Miller","year":"2011","unstructured":"Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, et al. PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas Aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients. Antimicrob Agents Chemother. 2011;55:5761\u201369.","journal-title":"Antimicrob Agents Chemother"},{"key":"822_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5507\/bp.2018.070","volume":"163","author":"P Mlynarcik","year":"2019","unstructured":"Mlynarcik P, Kolar M. Molecular Mechanisms of Polymyxin Resistance and Detection of Mcr Genes. Biomed Pap. 2019;163:28\u201338.","journal-title":"Biomed Pap"},{"key":"822_CR7","doi-asserted-by":"publisher","first-page":"e01083","DOI":"10.1128\/mBio.01083-19","volume":"10","author":"V Trebosc","year":"2019","unstructured":"Trebosc V, Gartenmann S, T\u00f6tzl M, Lucchini V, Schellhorn B, Pieren M, et al. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter Baumannii Clinical Isolates. mBio. 2019;10:e01083\u201319.","journal-title":"mBio"},{"key":"822_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10096-018-3223-9","volume":"37","author":"WG Lima","year":"2018","unstructured":"Lima WG, Alves MC, Cruz WS, Paiva MC. Chromosomally Encoded and Plasmid-mediated Polymyxins Resistance in Acinetobacter Baumannii: A Huge Public Health Threat. Eur J Clin Microbiol Infect Dis. 2018;37:1009\u201319.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"822_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/antibiotics8020038","volume":"8","author":"F Perez","year":"2019","unstructured":"Perez F, El Chakhtoura NG, Yasmin M, Bonomo RA. Polymyxins: To Combine or Not to Combine?. Antibiotics. 2019;8:38.","journal-title":"Antibiotics"},{"key":"822_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel L, Jayol A, Nordmann P. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes. Clin Microbiol Rev. 2017;30:557\u201396.","journal-title":"Clin Microbiol Rev"},{"key":"822_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/14787210.2018.1453807","volume":"16","author":"N Sherry","year":"2018","unstructured":"Sherry N, Howden B. Emerging Gram-negative Resistance to Last-Line Antimicrobial Agents Fosfomycin, Colistin and Ceftazidime-Avibactam \u2013 Epidemiology, Laboratory Detection and Treatment Implications. Expert Rev Anti Infect Ther. 2018;16:289\u2013306.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"822_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijantimicag.2016.11.029","volume":"49","author":"K Jeannot","year":"2017","unstructured":"Jeannot K, Bolard A, Pl\u00e9siat P. Resistance to Polymyxins in Gram-Negative Organisms. Int J Antimicrob Agents. 2017;49:526\u201335.","journal-title":"Int J Antimicrob Agents"},{"key":"822_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29234-3","volume":"13","author":"KD Roberts","year":"2022","unstructured":"Roberts KD. A Synthetic Lipopeptide Targeting Top-Priority Multidrug-Resistant Gram-Negative Pathogens. Nat Commun. 2022;13:1625.","journal-title":"Nat Commun"},{"key":"822_CR14","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1093\/jac\/dkaa217","volume":"75","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H, et al. Evaluation of the in Vitro Activity of New Polymyxin B Analogue SPR206 against Clinical MDR, Colistin-Resistant and Tigecycline-Resistant Gram-Negative Bacilli. J Antimicrob Chemother. 2020;75:2609\u201315.","journal-title":"J Antimicrob Chemother"},{"key":"822_CR15","doi-asserted-by":"publisher","first-page":"116924","DOI":"10.1016\/j.ejmech.2024.116924","volume":"280","author":"AL Cui","year":"2024","unstructured":"Cui AL, Yang HX, Yi H, Lv M, Peng XJ, Zheng GH, et al. Design, Synthesis, and Bioactivity Investigation of Novel Cyclic Lipopeptide Antibiotics Targeting Top-Priority Multidrug-Resistant Gram-Negative Bacteria. Eur J Med Chem. 2024;280:116924.","journal-title":"Eur J Med Chem"},{"key":"822_CR16","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1021\/acsinfecdis.9b00217","volume":"5","author":"P Brown","year":"2019","unstructured":"Brown P, Abbott E, Abdulle O, Boakes S, Coleman S, Divall N, et al. Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206. ACS Infect Dis. 2019;5:1645\u201356.","journal-title":"ACS Infect Dis"},{"key":"822_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1126\/science.aar1886","volume":"359","author":"DJ Sherman","year":"2018","unstructured":"Sherman DJ, Xie R, Taylor RJ, George AH, Okuda S, Foster PJ, et al. Lipopolysaccharide is transported to the cell surface by a membrane-to-membrane protein bridge. Science. 2018;359:798\u2013801.","journal-title":"Science"},{"key":"822_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrmicro.2016.25","volume":"14","author":"S Okuda","year":"2016","unstructured":"Okuda S, Sherman DJ, Silhavy TJ, Ruiz N, Kahne D. Lipopolysaccharide Transport and Assembly at the Outer Membrane: The PEZ Model. Nat Rev Microbiol. 2016;14:337\u201345.","journal-title":"Nat Rev Microbiol"},{"key":"822_CR19","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1016\/j.bmc.2016.05.027","volume":"24","author":"SU Vetterli","year":"2016","unstructured":"Vetterli SU, Moehle K, Robinson JA. Synthesis and Antimicrobial Activity against Pseudomonas Aeruginosa of Macrocyclic \u03b2-Hairpin Peptidomimetic Antibiotics Containing N-Methylated Amino Acids. Bioorg Med Chem. 2016;24:6332\u20139.","journal-title":"Bioorg Med Chem"},{"key":"822_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/14787210.2018.1441024","volume":"16","author":"I Martin-Loeches","year":"2018","unstructured":"Martin-Loeches I, Dale GE, Torres A. Murepavadin: A New Antibiotic Class in the Pipeline. Expert Rev Anti Infect Ther. 2018;16:259\u201368.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"822_CR21","doi-asserted-by":"publisher","first-page":"eadg3683","DOI":"10.1126\/sciadv.adg3683","volume":"9","author":"M Schuster","year":"2023","unstructured":"Schuster M, Brabet E, Oi KK, Desjonqu\u00e8res N, Moehle K, Le Poupon K, et al. Peptidomimetic Antibiotics Disrupt the Lipopolysaccharide Transport Bridge of Drug-Resistant Enterobacteriaceae. Sci Adv. 2023;9:eadg3683.","journal-title":"Sci Adv"},{"key":"822_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-023-06799-7","volume":"625","author":"KS Pahil","year":"2024","unstructured":"Pahil KS, Gilman M, Baidin V, Clairfeuille T, Mattei P, Bieniossek C, et al. A New Antibiotic Traps Lipopolysaccharide in Its Intermembrane Transporter. Nature. 2024;625:572\u20137.","journal-title":"Nature"},{"key":"822_CR23","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41564-022-01227-4","volume":"7","author":"RD Miller","year":"2022","unstructured":"Miller RD, Iinishi A, Modaresi SM, Yoo BK, Curtis TD, Lariviere PJ, et al. Computational Identification of a Systemic Antibiotic for Gram-Negative Bacteria. Nat Microbiol. 2022;7:1661\u201372.","journal-title":"Nat Microbiol"},{"key":"822_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-019-1791-1","volume":"576","author":"Y Imai","year":"2019","unstructured":"Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R, Manuse S, et al. A New Antibiotic Selectively Kills Gram-Negative Pathogens. Nature. 2019;576:459\u201364.","journal-title":"Nature"},{"key":"822_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-020-2597-x","volume":"584","author":"T Clairfeuille","year":"2020","unstructured":"Clairfeuille T, Buchholz KR, Li Q, Verschueren E, Liu P, Sangaraju D, et al. Structure of the Essential Inner Membrane Lipopolysaccharide-PbgA Complex. Nature. 2020;584:479\u201383.","journal-title":"Nature"},{"key":"822_CR26","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1021\/acsinfecdis.2c00406","volume":"8","author":"R Yamauchi","year":"2022","unstructured":"Yamauchi R, Kawano K, Yamaoka Y, Taniguchi A, Yano Y, Takasu K, et al. Development of Antimicrobial Peptide-Antibiotic Conjugates to Improve the Outer Membrane Permeability of Antibiotics Against Gram-Negative Bacteria. ACS Infect Dis. 2022;8:2339\u201347.","journal-title":"ACS Infect Dis"},{"key":"822_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41429-023-00606-1","volume":"76","author":"Y Li","year":"2023","unstructured":"Li Y, Dong Y, Lu J, Zhang J, Feng M, Feng J. Design, synthesis and antibacterial activity of novel colistin derivatives with thioether bond-mediated cyclic scaffold. J Antibiot. 2023;76:260\u20139.","journal-title":"J Antibiot"},{"key":"822_CR28","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL. Overview of Antibiotic-Induced Nephrotoxicity. Kidney Int Rep. 2023;8:2211\u201325.","journal-title":"Kidney Int Rep"},{"key":"822_CR29","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1128\/JCM.43.10.5243-5246.2005","volume":"43","author":"A Espinel-Ingroff","year":"2005","unstructured":"Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller M, et al. Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. J Clin Microbiol. 2005;43:5243\u20136.","journal-title":"J Clin Microbiol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00822-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:02:57Z","timestamp":1748296977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00822-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00822-x","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}